225 related articles for article (PubMed ID: 23688624)
1. Is there a role for radiotherapy in the primary management of primary central nervous system lymphoma? A single-centre case series.
Muirhead R; Murray EC; Bell SL; Stewart W; James A
Clin Oncol (R Coll Radiol); 2013 Jul; 25(7):400-5. PubMed ID: 23688624
[TBL] [Abstract][Full Text] [Related]
2. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
3. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
4. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
[TBL] [Abstract][Full Text] [Related]
5. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
7. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
9. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
10. Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases.
Bellinzona M; Roser F; Ostertag H; Gaab RM; Saini M
Eur J Surg Oncol; 2005 Feb; 31(1):100-5. PubMed ID: 15642434
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE
Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045
[TBL] [Abstract][Full Text] [Related]
12. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
[TBL] [Abstract][Full Text] [Related]
13. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.
Schuurmans M; Bromberg JE; Doorduijn J; Poortmans P; Taphoorn MJ; Seute T; Enting R; van Imhoff G; van Norden Y; van den Bent MJ
Br J Haematol; 2010 Oct; 151(2):179-84. PubMed ID: 20738305
[TBL] [Abstract][Full Text] [Related]
15. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
16. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
[TBL] [Abstract][Full Text] [Related]
17. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Laack NN; Ballman KV; Brown PB; O'Neill BP;
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1429-39. PubMed ID: 16863926
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
Raizer JJ; Rademaker A; Evens AM; Rice L; Schwartz M; Chandler JP; Getch CC; Tellez C; Grimm SA
Cancer; 2012 Aug; 118(15):3743-8. PubMed ID: 22179954
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
Omuro AM; DeAngelis LM; Yahalom J; Abrey LE
Neurology; 2005 Jan; 64(1):69-74. PubMed ID: 15642906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]